立陶宛卫生部长利纳斯·库库赖蒂斯周三表示，如果俄罗斯报告的肺鼠疫病例得到证实并构成威胁，立陶宛可能会限制俄罗斯公民经该国过境。
Lithuania may restrict the transit of Russian citizens through the country if a reported pneumonic plague case in Russia is confirmed and poses a threat, Health Minister Linas Kukuraitis said Wednesday.
库库赖蒂斯对立陶宛公共广播公司LRT说道：“哪怕只是出现最微小的威胁，我们也会提出这个问题，随后各方将共同做出决策。”
"If we saw even the slightest threat, this issue would be raised by us, and decisions would then be made jointly," Kukuraitis told Lithuanian public broadcaster LRT.
他还称，任何应对措施都会与欧盟协调，立陶宛也具备相应的应对程序及充足的药品储备以应对可能的疫情爆发。
He said any measures would be coordinated with the EU and that Lithuania had procedures and sufficient medication reserves to respond to a possible outbreak.
库库赖蒂斯强调，目前俄罗斯出现肺鼠疫病例的报道尚未得到独立证实。
Kukuraitis stressed that reports of a pneumonic plague case in Russia had not been independently confirmed.
他表示：“当前局势确实令人担忧，但我们也希望能安抚民众情绪。”
"It is both a worrying situation, and we would like to reassure the public," he said.
立陶宛国家公共卫生中心称，目前该国出现鼠疫感染的风险并未升高，相关病例报道也尚未得到独立证实。
Lithuania's National Public Health Centre said there was currently no increased risk of plague infection in the country and that the reported case could not be independently confirmed.
此前有报道称，一名在俄罗斯伊尔库茨克州一家鼠疫研究所工作的28岁女子死于肺鼠疫。不过俄罗斯官方称，该女子去世后进行的检测并未发现鼠疫病毒。
Reports emerged Friday that a 28-year-old woman who worked at a plague research institute in Russia's Irkutsk region had died of pneumonic plague. Russian officials, however, said tests conducted after her death did not detect the disease.
世界卫生组织周二表示，相关当局正在调查肺鼠疫是否为该女子的死因，目前尚未确定官方死因。世卫组织称，该女子的所有接触者均已被确认并处于监测之中，目前无人出现相关症状。
The World Health Organization said Tuesday that authorities were investigating whether pneumonic plague caused the woman's death and that no official cause of death had been confirmed. The WHO said all the woman's contacts had been identified and were being monitored, with none showing symptoms.
世卫组织的初步评估认为，伊尔库茨克地区的疫情风险处于中等偏低水平，整个俄罗斯的风险水平较低，而世卫组织欧洲区域的风险水平则极低。
Its initial assessment put the risk at moderate to low for Irkutsk, low for Russia as a whole and very low for the WHO European region.